Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

AAM. 2023; 12(3): 254-259


Screening of Anti fungal Activity of Arkamanashiladi Tailam - An In Vitro Study

Mrudula Divakaran, KL Virupaksha Gupta, B Saravanan.




Abstract

Superficial fungal infections are prevalent worldwide. Itching is one of the predominant symptoms in fungal infections, and the chances of reoccurrence are on the rise even after different therapeutic interventions in modern medicine. Physicians find it difficult to manage these infections due to drug resistance and adverse effects. There is a need for an effective intervention that can bridge the gap in conventional medicine. Ayurveda, one of the ancient known medicines, provides time-tested solutions for fungal infections. Arkamanashiladi tailam is is one time tested formulation indicated in Kushta (skin diease), Kandu (itching) by the text Chakradatha. This indicates its efficacy against itchy skin diseases like fungal infections. Arkamanashiladi Tailam is prepared with ingredients Arka Patra Swarasa (Calotropis gigantea Linn.), Katu tailam (essential oil of seeds of Brassica campestris) Shoditha Manashila (Realgar) and Haridra (Curcuma longa Linn.) with Katu tailam (mustard oil) base. This study carried out against five fungal species Candida albicans, Candida tropicalis, Microsporum gypseum, Epidermophyton floccosum,and Trycophyton rubrum. Katu tailam, Arkamanashiladi tailam test samples as trial samples and Fluconazole as standard drug sample anti fungal study carried out with agar well diffusion and disk diffusion method. It was found that Candida albicans and Candida tropicalis showed significant sensitivity towards Arkamanashiladi tailam.

Key words: Keywords: Arkamanashiladi tailam, Mustard oil,Antifungal study, Candida .






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.